Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

erlotinib-encapsulating irinotecan/riboflavin-containing PEG-based polymer nanoparticles

Based on

1 Articles
2016 Most recent source

Composition

1

erlotinib

ET
Type Single Compound
Formula C22H23N3O4
Role core
2

irinotecan-modified polyethyleneglycol-based 4-phenylazobenzoic acid derivative

AZO-C6-PEG-S-Ir polymer
Type Polymer
Formula
Role layer
3

riboflavin-modified polyethyleneglycol-based 4-phenylazobenzoic acid derivative

AZO-C6-PEG-R polymer
Type Polymer
Formula
Role layer

Properties

Applications

Characterization

Biological effects

Biological system Test details Source

Full content is available to subscribers only

To view content please choose from the following:

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • riboflavin-modified polyethyleneglycol-based 4-phenylazobenzoic acid derivative
  • erlotinib
  • irinotecan-modified polyethyleneglycol-based 4-phenylazobenzoic acid derivative
  1. QjTWYvwmSSe2u1b00tjVgaHJuS8Js4YsI61fI8mLviqNW49DnA17WSG0g6zsKYeZ3zk
Product

erlotinib-encapsulating irinotecan/riboflavin-containing PEG-based polymer nanoparticles

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial